 |
 |
Date Announced: 25 Apr 2012
Suit filed in Dusseldorf relates to "the output of optical energy of lasers".
IRVINE, CA (April 25, 2012) - BIOLASE Technology, Inc. (NASDAQ:BLTI), the World's leading dental laser manufacturer and distributor, today announced that it had filed a lawsuit in the Dusseldorf Patent Litigation Court asserting that one of its European competitors is infringing on BIOLASE European Patent EP 1 560 470, which relates to the output of optical energy of lasers. The lawsuit, filed on April 13, 2012, seeks both cash damages and injunctive relief from the courts. The lawsuit was filed after failed attempts were made to create an amicable business arrangement between the two companies.
Federico Pignatelli, Chairman and CEO, said, "BIOLASE is committed to asserting its rights in its extensive patent portfolio in the U.S. and internationally. With more than 280 U.S. and international patents and patents pending, the Company has invested heavily in its intellectual property portfolio for laser dentistry and other medical fields. We will not tolerate what we believe to be infringement of our patents, and we will be very aggressive in protecting our rights."
Source: Biolase
E-mail: via web site
Web Site: www.biolase.com
| © 2024 SPIE Europe |
|
